Close
Help




JOURNAL

Clinical Medicine Insights: Therapeutics

Management Options in Chronic Obstructive Pulmonary Disease

Submit a Paper


Clinical Medicine Insights: Therapeutics 2012:4 273-285

Review

Published on 13 Sep 2012

DOI: 10.4137/CMT.S6563


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Therapeutics

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading respiratory disease in the world and third leading cause of death in United States. COPD is not recognized as an isolated respiratory disease anymore; in fact it is one of the dreaded diseases with significant systemic involvement and complications. Treatment of COPD requires team work and efforts among physicians, nurses, respiratory therapists and physical therapists. Treatment of patients with frequent exacerbations is a heavy burden on healthcare network. In the last few years, some improvements in the management of COPD have been made, owing to new drugs and management strategies, along with non-pharmacologic treatment of COPD with pulmonary rehabilitation and surgical interventions. Smoking cessation is still the best strategy to prevent COPD and prevent further progression of disease. In this review, we discuss pharmacotherapy of COPD including management of acute exacerbations, pharmacotherapy for smoking cessation and role of vaccination in COPD patients.



Downloads

PDF  (627.76 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

Supplementary Files 1   (43.36 MB MP4 FORMAT)

BibTex citation   (BIBDESK, LATEX)


Video Abstract



Quick Links


New article and journal news notification services